Answers are grounded in this paper and cite their sources.
Relapsing polychondritis (RP) is a rare autoimmune disorder that has been associated with various other autoimmune conditions. There have been no reported cases about any patient with psoriasis who has experienced RP recurrence associated with a change in biologic therapy. This is only the second case of a patient developing RP or RP recurrence associated with an Interleukin-17 A inhibitor or Tumor Necrosis Factor alpha inhibitor cessation. We present this case to increase physician awareness of a relationship between IL-17 A inhibitor use and the induction of relapsing polychondritis. In addition, we explore current literature related to IL-17 A inhibitor use in psoriasis.
No takes yet. Share an insight, caveat, or question.
Turnbough et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: